Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADAM: M207 Safety in Migraine
NCT03282227Phase 3Completed
- Sponsor
- Zosano Pharma
- Start
- Nov 2017
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of zolmitriptan in migraine, sponsored by Zosano Pharma. Started Nov 2017; status: completed.
02
Drugs
zolmitriptan
03
Conditions
migraine
Beyond the preview
Go deeper on NCT03282227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03282227.